TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1176972

Group type: EXPERIMENTAL
Intervention: Drug alleged to induce flashbacks (specific drug not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ephedrine sulfate (causing autonomic changes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30732940

Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg once daily)
Number of subjects: 627

Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir (800 mg lopinavir plus 200 mg ritonavir once daily or 400 mg plus 100 mg twice daily)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 627

Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir
Number of subjects: 627
Study: 28300357

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (sham-remote ischemic preconditioning)
Number of subjects: 45
Study: 25877139

Group type: COMPARATOR
Intervention: IGT no‐intervention group
Number of subjects: 1096

Group type: COMPARATOR
Intervention: NGT group
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: IGT intervention subjects
Number of subjects: 1096

Group type: COMPARATOR
Intervention: IGT no‐intervention group vs NGT group
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: IGT intervention group vs NGT group
Number of subjects: 1096
Study: 23485720

Group type: EXPERIMENTAL
Intervention: Lactulose (group A, n = 63)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No lactulose (group B, n = 65)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No lactulose (group B)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lactulose (group A)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Patients who developed HE
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lactulose therapy
Number of subjects: 128
Study: 21683280

Group type: EXPERIMENTAL
Intervention: Fresh fruit deliveries (1 serving per employee, 3 days a week for 12 weeks)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control (no fruit deliveries)
Number of subjects: 528
Study: 19499869

Group type: EXPERIMENTAL
Intervention: Forced air warming device (Warm-touch)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Radiant warming device (Sun-touch)
Number of subjects: 29
Study: 16460251

Group type: EXPERIMENTAL
Intervention: 0.2% CHX spray
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.03% TRN spray
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.05% CPC spray
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.12% CHX rinse
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.2% CHX rinse
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline solution (negative control)
Number of subjects: 15
Study: 15166643

Group type: EXPERIMENTAL
Intervention: alanine + alcohol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: alanine + alcohol + methylene blue
Number of subjects: 11

Group type: COMPARATOR
Intervention: alanine infusion (control)
Number of subjects: 11
Study: 11813896

Group type: EXPERIMENTAL
Intervention: Azithromycin at a dose of 10 mg/kg once daily for 3 days, repeated weekly for up to 12 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Azithromycin at a dose of 10 mg/kg once daily for 3 days for the first week, repeated for 1 day a week for the following 11 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pseudoephedrine hydrochloride (PHCl), 4 mg/kg, 3 times daily for up to 12 weeks
Number of subjects: 90
Study: 9502552

Group type: EXPERIMENTAL
Intervention: Computerized attention remediation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Video documentaries (Control)
Number of subjects: 54
Study: 7981085

Group type: EXPERIMENTAL
Intervention: 12 cycles of polychemotherapy (CMF)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Post-operative radiotherapy
Number of subjects: 208
Study: 3140572

Group type: EXPERIMENTAL
Intervention: GnRH-agonist (buserelin) 400 micrograms intranasally once daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 4899454

Group type: EXPERIMENTAL
Intervention: Tetracycline for the first two winters and placebo for the next three
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Placebo for the first two winters and tetracycline for the next three
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Tetracycline for five winters
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo throughout the winter months for five years
Number of subjects: 79
Study: 31851874

Group type: EXPERIMENTAL
Intervention: Learning Chinese Internet Language
Number of subjects: 62

Group type: COMPARATOR
Intervention: Scientific terminology (Control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: More experienced group
Number of subjects: 62
Study: 29929350

Group type: EXPERIMENTAL
Intervention: Serological testing for Mycoplasma pneumoniae
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Serological testing for Chlamydia pneumoniae
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Serological testing for Legionella pneumophila
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Multiplex PCR testing for atypical pathogens
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Urinary antigen test for Legionella pneumophila
Number of subjects: 341
Study: 28931404

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including decision analysis tool, ultrasound evaluation, prediction tool, and best practices for intrapartum management
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study: 26432172

Group type: EXPERIMENTAL
Intervention: Schema Therapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Transference Focused Psychotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: In-session dissociation (mediated effect)
Number of subjects: 86
Study: 23223332

Group type: EXPERIMENTAL
Intervention: Docetaxel-cisplatin (TP)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Docetaxel-capecitabine (TX)
Number of subjects: 53
Study: 21247517

Group type: EXPERIMENTAL
Intervention: ivabradine 5 or 7.5 mg/day
Number of subjects: 840
Study: 18424987

Group type: EXPERIMENTAL
Intervention: Fiducial markers (FM) registration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Anatomic landmarks (AL) registration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Surface-merged (SM) registration
Number of subjects: 30
Study: 16493528

Group type: EXPERIMENTAL
Intervention: Drains inserted (Group 1, 68 patients)
Number of subjects: 135

Group type: COMPARATOR
Intervention: No drains inserted (Group 2, 67 patients)
Number of subjects: 135
Study: 12610188

Group type: EXPERIMENTAL
Intervention: paclitaxel, estramustine, and oral etoposide (TEE)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: ketoconazole/doxorubicin alternating with vinblastine/estramustine (KA/VE)
Number of subjects: 71
Study: 10480221

Group type: EXPERIMENTAL
Intervention: 4 IU/m2/day of recombinant human growth hormone (rhGH)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 8721467

Group type: EXPERIMENTAL
Intervention: 75 mg hyperbaric lignocaine 5%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 100 mg hyperbaric lignocaine 5%
Number of subjects: 20
Study: 2302517

Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy (HSV)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Truncal vagotomy and pyloroplasty (TVP)
Number of subjects: 116
Study: 536101

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 2
Study: 30642119

Group type: EXPERIMENTAL
Intervention: Improved Genetic Algorithm (IGA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Genetic Algorithm (CGA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline Random Choice Algorithm (RCA)
Number of subjects: 0
Study: 29019899

Group type: EXPERIMENTAL
Intervention: gynecological laparoscopic surgery with mannitol treatment (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: laparoscopic cholecystectomy surgery (Group C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: gynecological laparoscopic surgery (Group A)
Number of subjects: 90
Study: 25822010

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 3 months (teaching coping skills)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Supportive nondirective therapy (supportive listening)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) after excluding subjects on >20 mg/d prednisone equivalent (n = 34)
Number of subjects: 161
Study: 24575949

Group type: EXPERIMENTAL
Intervention: Kinesiologic taping (KT)
Number of subjects: 96
Study: 22371350

Group type: EXPERIMENTAL
Intervention: Baby BEEP trial
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Baby Beep for Kids trial
Number of subjects: 695

Group type: COMPARATOR
Intervention: State of Missouri
Number of subjects: 695

Group type: COMPARATOR
Intervention: United States
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Adverse pregnancy outcomes
Number of subjects: 695
Study: 21059778

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg intravenous every six hours until hemodynamic stability, followed by tapering over eight days)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 17701167

Group type: EXPERIMENTAL
Intervention: Movina (St. John's wort product)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (multivitamin tablet Vitamineral)
Number of subjects: 16
Study: 15843812

Group type: EXPERIMENTAL
Intervention: SIMV + PS3 (Pressure Support at 3 cmH(2)O)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SIMV + PS6 (Pressure Support at 6 cmH(2)O)
Number of subjects: 15

Group type: COMPARATOR
Intervention: SIMV (Control)
Number of subjects: 15
Study: 12081840

Group type: EXPERIMENTAL
Intervention: n-3 Polyunsaturated fatty acids (PUFAs)
Number of subjects: 10
Study: 9527202

Group type: EXPERIMENTAL
Intervention: Reduced prime (RP) volume (600 to 800 mL)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Full prime (FP) volume (1,400 mL of Plasmalyte solution)
Number of subjects: 114
Study: 7608350

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychotherapy (CB)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal psychotherapy (PI)
Number of subjects: 104
Study: 2908258

Group type: EXPERIMENTAL
Intervention: Fansimef (1 tablet containing 250 mg mefloquine + 500 mg sulfadoxine + 25 mg pyrimethamine per week)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Chloroquine (300 mg per week)
Number of subjects: 211
Study: 31621253

Group type: EXPERIMENTAL
Intervention: Zhishen Tiaosui acupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 64
Study: 28104287

Group type: COMPARATOR
Intervention: Reference group (quaternary ammonium disinfectant for all except C difficile, which used bleach)
Number of subjects: 31226

Group type: EXPERIMENTAL
Intervention: UV group (quaternary ammonium disinfectant and disinfecting UV-C light for all except C difficile, which used bleach and UV-C)
Number of subjects: 31226

Group type: EXPERIMENTAL
Intervention: Bleach group (bleach used for disinfection)
Number of subjects: 31226

Group type: EXPERIMENTAL
Intervention: Bleach and UV group (bleach and UV-C used for disinfection)
Number of subjects: 31226

Group type: EXPERIMENTAL
Intervention: UV group (with bleach)
Number of subjects: 31226
Study: 26265279

Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (6 mmHg) with deep neuromuscular block
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal pressure pneumoperitoneum (12 mmHg) with deep neuromuscular block
Number of subjects: 64
Study: 23816039

Group type: EXPERIMENTAL
Intervention: Phytosterol tablets 900 mg twice daily
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Lifestyle change (LC) program
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Red yeast rice (RYR) 1800 mg twice daily
Number of subjects: 187
Study: 21430512

Group type: EXPERIMENTAL
Intervention: Tendon gliding exercises with conventional treatments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nerve gliding exercises with conventional treatments
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatments (splint and paraffin therapy)
Number of subjects: 60
Study: 18303436

Group type: EXPERIMENTAL
Intervention: Adjuvant NIP (47% of randomized patients)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Observation (53% of randomized patients)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Induction NIP (after three cycles)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Induction NIP (tolerance)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Adjuvant NIP (tolerance)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Surgery after induction NIP
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Downstaging after surgery
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Operative mortality rate
Number of subjects: 156
Study: 20142790

Group type: EXPERIMENTAL
Intervention: Soy isoflavone tablets (80 or 120 mg/d)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Soy isoflavone treatment
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Dietary fat
Number of subjects: 229
Study: 16214632

Group type: EXPERIMENTAL
Intervention: Test tooth (orthodontically treated)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control tooth (not subjected to mechanical stress)
Number of subjects: 16
Study: 12140347

Group type: EXPERIMENTAL
Intervention: Intervention designed to alter perceptions about MI
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual care from rehabilitation nurses
Number of subjects: 65
Study: 9603534

Group type: EXPERIMENTAL
Intervention: Systemic antibiotic prophylaxis
Number of subjects: 2023

Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 2023
Study: 7923674

Group type: EXPERIMENTAL
Intervention: Treadmill walking exercise
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Treadmill walking exercise after initial 12 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined strength and treadmill training after initial 12 weeks
Number of subjects: 29
Study: 2462383

Group type: EXPERIMENTAL
Intervention: 400 micrograms albuterol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 mg albuterol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 mg albuterol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 mg albuterol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31441049

Group type: EXPERIMENTAL
Intervention: Cooling at 16°C for 20 minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Increased duration of contact at 70°C
Number of subjects: 25
Study: 26526783

Group type: EXPERIMENTAL
Intervention: SynergyTM stent at 3 months
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: SynergyTM stent at 6 months
Number of subjects: 42
Study: 24645726

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SR)
Number of subjects: 0
Study: 22124356

Group type: EXPERIMENTAL
Intervention: Nonionized compression tights
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ionized compression tights
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard running tights (control)
Number of subjects: 10
Study: 19968890

Group type: EXPERIMENTAL
Intervention: Higher tertile of EPA+DHA intake
Number of subjects: 644

Group type: COMPARATOR
Intervention: Fish intake
Number of subjects: 644
Study: 17415634

Group type: EXPERIMENTAL
Intervention: Da-Cheng-Qi-Tang (DCQT)
Number of subjects: 69
Study: 15474696

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 11341416

Group type: EXPERIMENTAL
Intervention: SF-12
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: Oxford-12
Number of subjects: 3600

Group type: COMPARATOR
Intervention: NHP, SF-12, SF-36, SIP, Lequesne, Oxford-12, WOMAC
Number of subjects: 3600
Study: 9558127

Group type: EXPERIMENTAL
Intervention: Vancomycin (VCM)
Number of subjects: 190
Study: 8061901

Group type: EXPERIMENTAL
Intervention: rIFN‐gamma 1.8 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: rIFN‐gamma 0.2 mg and 0.6 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: rIFN‐gamma
Number of subjects: 6
Study: 3421209

Group type: EXPERIMENTAL
Intervention: omega‐3 TG (triglyceride rich in omega‐3 FAs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: omega‐3 ME (methyl esters)
Number of subjects: 8

Group type: COMPARATOR
Intervention: control (18 vegetable-oil capsules)
Number of subjects: 8
Study: 30068614

Group type: EXPERIMENTAL
Intervention: Active Communication Education (ACE) programme plus hearing aid provision
Number of subjects: 84

Group type: COMPARATOR
Intervention: Hearing aid provision alone
Number of subjects: 84
Study: 27391922

Group type: EXPERIMENTAL
Intervention: Home enteral nutrition (HEN)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nutritional counselling
Number of subjects: 79
Study: 25907350

Group type: EXPERIMENTAL
Intervention: Betaferon
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Avonex
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rebif
Number of subjects: 90
Study: 23957526

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HYP), 7 sessions
Number of subjects: 54

Group type: COMPARATOR
Intervention: Attention control (CON)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HYP)
Number of subjects: 54
Study: 22212275

Group type: EXPERIMENTAL
Intervention: Moderate Intensity (MI) resistance training (45‐55% 1RM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High Intensity (HI) resistance training (80‐90% 1RM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 30
Study: 18362623

Group type: EXPERIMENTAL
Intervention: Bar-coded sponge system
Number of subjects: 300

Group type: COMPARATOR
Intervention: Traditional counting protocol
Number of subjects: 300
Study: 17168363

Group type: EXPERIMENTAL
Intervention: Focal radiotherapy (20‐24 Gy) in accelerated hyperfractionation (1.3‐1.5 Gy, twice a day, at 5‐hr interval)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard fractionation (38‐40 Gy)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Focal radiotherapy (20‐24 Gy) in accelerated hyperfractionation
Number of subjects: 117
Study: 12584541

Group type: EXPERIMENTAL
Intervention: Training group (TG, n = 9) - individualized training on a cycle ergometer, exercising at an intensity set at the heart rate corresponding to the ventilatory threshold, with 1‐minute sprints against the maximal aerobic power (MAP) every 4 minutes, 45 minutes per session, 3 sessions per week
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG, n = 7) - no specific intervention mentioned
Number of subjects: 16
Study: 10588785

Group type: EXPERIMENTAL
Intervention: Dense spontaneous echocardiographic contrast (SEC)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Any density of spontaneous echocardiographic contrast (SEC)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Clinical, echocardiographic, and hemostatic parameters
Number of subjects: 772
Study: 8733683

Group type: COMPARATOR
Intervention: 4 g/m2 cyclophosphamide (CY)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 7 g/m2 cyclophosphamide (CY)
Number of subjects: 32
Study: 1929094

Group type: EXPERIMENTAL
Intervention: Gentamicin 0.3% one drop every three hours the night before and the morning of surgery (half‐day regimen)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Gentamicin 0.3% one drop qid for three days (three‐day regimen)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Povidone-iodine 5% preparation
Number of subjects: 15
Study: 7075329

Group type: EXPERIMENTAL
Intervention: Father treatment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Mother treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Treatment (both father and mother)
Number of subjects: 42
Study: 31601449

Group type: COMPARATOR
Intervention: Total nuts (10+ g/day)
Number of subjects: 62573

Group type: COMPARATOR
Intervention: Tree nuts, peanuts, peanut butter
Number of subjects: 62573
Study: 30672303

Group type: EXPERIMENTAL
Intervention: High-intensity laser therapy + exercise therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham-laser + exercise therapy
Number of subjects: 46
Study: 27624151

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 26498439

Group type: EXPERIMENTAL
Intervention: Proton radiation therapy (PRT)
Number of subjects: 20
Study: 24368307

Group type: EXPERIMENTAL
Intervention: CNTF‐3 low-dose implant
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CNTF‐3 high-dose implant
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CNTF‐4 high-dose implant
Number of subjects: 8
Study: 22608696

Group type: EXPERIMENTAL
Intervention: P3P intervention
Number of subjects: 494

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 494
Study: 18974967

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lisinopril 40 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lisinopril 60 mg
Number of subjects: 49
Study: 17300401

Group type: EXPERIMENTAL
Intervention: EXPORT catheter
Number of subjects: 129

Group type: COMPARATOR
Intervention: Stent implantation
Number of subjects: 129
Study: 14725952

Group type: EXPERIMENTAL
Intervention: 50 mg propoxyphene napsylate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 mg propoxyphene napsylate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 mg propoxyphene napsylate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 40 mg morphine sulfate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 2 mg lorazepam
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11577993

Group type: EXPERIMENTAL
Intervention: (1‐‐>3)‐beta‐D‐glucan inhalation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline inhalation
Number of subjects: 21